Literature DB >> 23269312

Application and validation of a new histologic staging and grading system for primary biliary cirrhosis.

Kenichi Harada1, Maylee Hsu, Hiroko Ikeda, Mikio Zeniya, Yasuni Nakanuma.   

Abstract

BACKGROUND: We proposed a new grading and staging system for primary biliary cirrhosis (PBC), which takes into account the degree of both chronic cholangitis activity (CA) and hepatitic activity (HA) for grading disease activity and that of fibrosis, bile duct loss, and chronic cholestasis for staging. In this study, we validated our new system.
METHODS: Using liver biopsy specimens from 166 cases of PBC, chronic cholangitis with mild periductal lymphoplasmacytic infiltration, including chronic nonsuppurative destructive cholangitis, and the combined activity of interface hepatitis and lobular hepatitis were categorized into 4 grades on the basis of their degree and distribution (CA0-3 and HA0-3, respectively). For staging, because orcein staining was not available in this study, 2 criteria (fibrosis and bile duct loss) were independently scored from 0 to 3 on the basis of their degrees, and a final stage score was created from the sum.
RESULTS: Although there was a relatively uniform distribution of CA0/1/2/3 cases, the cases of HA0/1/2/3 were distributed as 21%, 64%, 13%, and 3%, respectively, with a prominent number of cases categorized as having none or mild HA. The distribution of stages 1 to 4 using our system was considerably different from that using the classic system and, importantly, showed a correlation with patient outcome.
CONCLUSIONS: Our system revealed that the activities of chronic cholangitis and hepatitis did not correlate with each other in terms of degree and that our staging system properly reflected the outcome of PBC patients. The present study could validate the effectiveness of this new system for characterizing the pathologic condition of PBC.

Entities:  

Mesh:

Year:  2013        PMID: 23269312     DOI: 10.1097/MCG.0b013e31827234e4

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.

Authors:  Mio Kobayashi; Yuko Kakuda; Kenichi Harada; Yasunori Sato; Motoko Sasaki; Hiroko Ikeda; Mitsuhiro Terada; Munenori Mukai; Shuichi Kaneko; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

2.  Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.

Authors:  Binu V John; Nidah S Khakoo; Kaley B Schwartz; Gabriella Aitchenson; Cynthia Levy; Bassam Dahman; Yangyang Deng; David S Goldberg; Paul Martin; David E Kaplan; Tamar H Taddei
Journal:  Am J Gastroenterol       Date:  2021-09-01       Impact factor: 12.045

3.  Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?

Authors:  Panagiotis A Papamichalis; Kalliopi Zachou; Roidoula A Papamichali; Maria Ioannou; Nikolaos K Gatselis; George N Dalekos; George K Koukoulis
Journal:  J Transl Int Med       Date:  2021-03-31

Review 4.  Current understanding of primary biliary cholangitis.

Authors:  Atsushi Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-12-03

Review 5.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06

Review 6.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28

7.  APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.

Authors:  Hong You; Xiong Ma; Cumali Efe; Guiqiang Wang; Sook-Hyang Jeong; Kazumichi Abe; Weijia Duan; Sha Chen; Yuanyuan Kong; Dong Zhang; Lai Wei; Fu-Sheng Wang; Han-Chieh Lin; Jin Mo Yang; Tawesak Tanwandee; Rino A Gani; Diana A Payawal; Barjesh C Sharma; Jinlin Hou; Osamu Yokosuka; A Kadir Dokmeci; Darrell Crawford; Jia-Horng Kao; Teerha Piratvisuth; Dong Jin Suh; Laurentius A Lesmana; Jose Sollano; George Lau; Shiv K Sarin; Masao Omata; Atsushi Tanaka; Jidong Jia
Journal:  Hepatol Int       Date:  2022-02-04       Impact factor: 6.047

8.  Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.

Authors:  Nora Cazzagon; Samantha Sarcognato; Annarosa Floreani; Giorgia Corrà; Sara De Martin; Vincenza Guzzardo; Francesco Paolo Russo; Maria Guido
Journal:  JHEP Rep       Date:  2021-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.